Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-19-045178
Filing Date
2019-08-12
Accepted
2019-08-12 07:17:13
Documents
60
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a19-13195_110q.htm 10-Q 1171805
2 EX-31.1 a19-13195_1ex31d1.htm EX-31.1 11899
3 EX-31.2 a19-13195_1ex31d2.htm EX-31.2 11987
4 EX-32.1 a19-13195_1ex32d1.htm EX-32.1 8782
  Complete submission text file 0001104659-19-045178.txt   4355160

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT akro-20190630.xml EX-101.INS 741117
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT akro-20190630.xsd EX-101.SCH 41532
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT akro-20190630_cal.xml EX-101.CAL 29972
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT akro-20190630_lab.xml EX-101.LAB 350901
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT akro-20190630_pre.xml EX-101.PRE 274806
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT akro-20190630_def.xml EX-101.DEF 118115
Mailing Address 170 HARBOR WAY SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY SOUTH SAN FRANCISCO CA 94080 650-487-6488
Akero Therapeutics, Inc. (Filer) CIK: 0001744659 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38944 | Film No.: 191014373
SIC: 2834 Pharmaceutical Preparations